Using animal models to develop new treatments for tuberculosis

Area of Science:

• Preclinical research
• Drug discovery
• Infectious diseases

Background:

• Animal models are crucial for evaluating new antituberculosis drug candidates.
• Mice are the most common and economical model for experimental tuberculosis chemotherapy.
• While not perfectly mimicking human disease, mice offer reliable data when experimental conditions are optimized.

Purpose of the Study:

• To review considerations for selecting animal models in tuberculosis research.
• To present a sequential evaluation model for new antituberculosis compounds.
• To highlight the utility of mice and guinea pigs in preclinical drug development.

Main Methods:

• Review of existing literature on animal models for tuberculosis.
• Discussion of experimental condition optimization for mouse models.
• Proposal of a sequential evaluation framework for drug candidates.

Main Results:

• Mice provide reliable data on the bactericidal and sterilizing activity of antituberculosis drugs.
• Optimized mouse models have informed numerous clinical trials.
• Guinea pig models can be useful for confirmatory or alternative preclinical evaluations.

Conclusions:

• The mouse is a well-established and cost-effective model for antituberculosis drug screening.
• Careful optimization of experimental conditions is key to obtaining reliable data from mouse models.
• Alternative models like the guinea pig may offer complementary insights in specific tuberculosis research scenarios.